Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imlifidase for acute AQP4-IgG positive NMOSD relapse
NL-OMON53456Phase 2Not yet recruiting
- Sponsor
- neurologie
- Start
- Dec 2023
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of imlifidase, sponsored by neurologie. Planned start Dec 2023; status: not yet recruiting.
02
Drugs
imlifidase
Beyond the preview
Go deeper on NL-OMON53456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON53456.